BioTech Startup

Cellino, a pioneering biotechnology company focused on autonomous biomanufacturing for personalized regenerative medicine, has announced its strategic expansion into the Asia-Pacific region through a partnership with Karis Bio, a...

European life sciences investor Sofinnova Partners has closed its new biotechnology-focused fund, Biovelocita II, raising €165 million (over $180 million) to support emerging drugmakers. The fund has already launched...

Dimension, a biotech venture firm founded by former Lux Capital and Obvious Ventures investors, has raised its second fund, Dimension II, which totals $500 million, surpassing the $350 million...

Nintx (Next Innovative Therapeutics), a biotech company focused on developing treatments for multifactorial diseases using Brazil’s biodiversity, has raised an additional US$ 10 million following a US$ 3 million...